Your browser doesn't support javascript.
loading
Pre-treatment condition effects on blood pressure and heart rate variability change in patients with arterial hypertension on therapy.
Talabanov, P G; Kozlovskaya, I L; Ryabykina, G V; Sobolev, A V; Kozhemyakina, E Sh.
Afiliação
  • Talabanov PG; Hospital №8, Obninsk district, Kaluga region, Obninsk, Russia.
  • Kozlovskaya IL; National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Ryabykina GV; National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Sobolev AV; National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.
  • Kozhemyakina ES; National Medical Research Center of Cardiology of the Ministry of Health of the Russian Federation, Moscow, Russia.
Ter Arkh ; 90(12): 23-27, 2018 Dec 30.
Article em En | MEDLINE | ID: mdl-30701829
AIM: To study the relationship of the initial clinical and functional state of patients with arterial hypertension (AH) with the dynamics of daily indices of blood pressure (BP) and sinus rhythm on antihypertensive therapy. MATERIALS AND METHODS: 38 patients were examined (general clinical examination, electrocardiography, echocardiography, daily bifunctional monitoring with the determination of weighted average rhythmogram variations - WARV, clinical and biochemical analysis of blood, glycated hemoglobin, thyroid hormones) and distribyted according to the use of hypotensive drugs of main classes and combined therapy AH. Dynamic monitoring of the effectiveness of treatment was carried out (after 2-4 weeks, then every 1-2 months), clinically and with bifunctional monitoring, correction of therapy. The observation period was 8 months. RESULTS: By the end of the study, 27 patients had target blood pressure, significant decrease in systolic / diastolic blood pressure (10/5 mm Hg and more) occurred in 30 patients. A correlation was found between the effectiveness of antihypertensive treatment and the initial clinical and instrumental parameters of patients: age, heart size (including left ventricular hypertrophy - LVH), thyroid stimulating blood hormone (TSH) level and fasting blood glucose (within normal limits). The level of WARV also correlated with these indicators and was significantly higher in patients who achieved a significant reduction in blood pressure. No significant dynamics of WARV was detected. No relationship between baseline blood pressure with WARV and their changes were identified. The connection of the myocardial mass index with the level of TSH and glycated hemoglobin was demostrated. CONCLUSION: The WARV reflects the severity of organic heart changes associated with age, disease duration, metabolic profile, LVH - heart damage as a target organ in AH, but is not suitable for analyzing its functional changes within one stage of the disease.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Hipertensão / Anti-Hipertensivos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pressão Sanguínea / Hipertensão / Anti-Hipertensivos Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article